Header Logo

Meenakshi Jolly

Concepts (302)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lupus Erythematosus, Systemic
77
2023
192
21.270
Why?
Quality of Life
41
2023
661
7.800
Why?
Surveys and Questionnaires
22
2023
1216
2.830
Why?
Severity of Illness Index
28
2020
988
2.460
Why?
Health Status
11
2018
224
2.420
Why?
Patient Reported Outcome Measures
11
2021
506
2.290
Why?
Psychometrics
16
2022
244
2.280
Why?
Rheumatology
6
2019
85
1.910
Why?
Adult
55
2022
8107
1.910
Why?
Body Image
6
2017
27
1.890
Why?
Self Report
8
2023
221
1.750
Why?
Female
66
2022
15730
1.690
Why?
Middle Aged
48
2021
9269
1.680
Why?
Humans
86
2023
28436
1.590
Why?
Reproducibility of Results
20
2022
737
1.450
Why?
Cross-Cultural Comparison
9
2022
40
1.430
Why?
Patient Outcome Assessment
3
2015
41
1.370
Why?
Hydroxychloroquine
3
2021
10
1.320
Why?
Male
49
2022
15291
1.300
Why?
Lupus Erythematosus, Discoid
3
2021
9
1.240
Why?
Antirheumatic Agents
3
2021
86
1.220
Why?
Rheumatologists
2
2018
15
1.180
Why?
Pain
7
2020
405
1.010
Why?
Cross-Sectional Studies
14
2021
933
1.000
Why?
Fatigue
4
2020
64
0.920
Why?
Lupus Erythematosus, Cutaneous
2
2014
5
0.890
Why?
Health Status Indicators
3
2014
75
0.870
Why?
Interferon-alpha
7
2014
32
0.790
Why?
Pneumococcal Infections
1
2021
7
0.770
Why?
Depression
4
2020
452
0.750
Why?
Quality of Health Care
3
2023
126
0.740
Why?
Antibodies, Antinuclear
5
2018
13
0.720
Why?
Sickness Impact Profile
4
2014
13
0.710
Why?
Pain Measurement
5
2019
472
0.710
Why?
Lupus Nephritis
2
2017
32
0.620
Why?
Outpatient Clinics, Hospital
1
2018
15
0.620
Why?
Delivery of Health Care, Integrated
1
2018
25
0.610
Why?
Quality Indicators, Health Care
1
2018
38
0.600
Why?
Academic Medical Centers
1
2019
137
0.580
Why?
Young Adult
12
2020
2069
0.570
Why?
Cost of Illness
2
2015
53
0.570
Why?
Factor Analysis, Statistical
7
2020
63
0.570
Why?
Sleep Wake Disorders
1
2019
130
0.570
Why?
Unnecessary Procedures
1
2017
30
0.550
Why?
Culture
2
2013
27
0.530
Why?
Physicians
3
2015
124
0.530
Why?
Tattooing
2
2007
3
0.530
Why?
Adolescent
11
2020
2307
0.530
Why?
Practice Patterns, Physicians'
1
2017
122
0.510
Why?
Canada
4
2018
51
0.510
Why?
Language
6
2022
71
0.500
Why?
Biological Products
1
2016
45
0.500
Why?
Linear Models
6
2018
251
0.480
Why?
Arthritis, Rheumatoid
4
2019
263
0.470
Why?
Immunoglobulin kappa-Chains
1
2014
2
0.460
Why?
Immunoglobulin lambda-Chains
1
2014
2
0.460
Why?
Interleukin-10
1
2014
20
0.460
Why?
United States
7
2018
2201
0.450
Why?
Interleukin-6
1
2014
79
0.450
Why?
Autoantibodies
8
2013
80
0.440
Why?
Posterior Leukoencephalopathy Syndrome
1
2013
9
0.430
Why?
Patient Education as Topic
1
2014
160
0.430
Why?
Treatment Outcome
10
2018
3615
0.430
Why?
Teaching
2
2019
62
0.420
Why?
Cultural Characteristics
1
2013
21
0.420
Why?
Dermatology
1
2012
6
0.410
Why?
Diagnostic Self Evaluation
1
2012
14
0.410
Why?
Hospitals, County
1
2012
3
0.410
Why?
Hospitals, University
1
2012
28
0.400
Why?
Longitudinal Studies
6
2020
1384
0.400
Why?
Adaptation, Psychological
5
2016
183
0.390
Why?
Caregivers
1
2015
205
0.390
Why?
Body Dysmorphic Disorders
1
2011
2
0.390
Why?
Polymorphism, Single Nucleotide
8
2017
284
0.390
Why?
Emotions
3
2017
78
0.390
Why?
Immunoglobulin Light Chains
1
2011
6
0.370
Why?
Aged
10
2021
9277
0.350
Why?
Genetic Predisposition to Disease
6
2018
390
0.350
Why?
Benchmarking
1
2010
37
0.340
Why?
Demography
1
2010
73
0.340
Why?
Income
1
2010
78
0.330
Why?
Clinical Trials as Topic
4
2016
239
0.330
Why?
Cognitive Dysfunction
1
2019
1065
0.320
Why?
Predictive Value of Tests
4
2017
492
0.310
Why?
Activities of Daily Living
2
2012
608
0.310
Why?
Case-Control Studies
6
2014
594
0.310
Why?
Stress, Psychological
3
2020
241
0.300
Why?
Randomized Controlled Trials as Topic
3
2016
330
0.300
Why?
Paracentesis
1
2007
4
0.280
Why?
Vasculitis, Leukocytoclastic, Cutaneous
1
2007
2
0.280
Why?
Suction
1
2007
40
0.280
Why?
Genital Diseases, Female
1
2006
5
0.270
Why?
Reference Values
3
2014
194
0.270
Why?
Chronic Disease
2
2005
441
0.270
Why?
Hyperuricemia
1
2006
4
0.260
Why?
Takayasu Arteritis
1
2005
1
0.250
Why?
Uveitis
1
2005
10
0.250
Why?
Chicago
2
2018
946
0.250
Why?
Metabolic Syndrome
1
2006
62
0.250
Why?
Leukoencephalopathy, Progressive Multifocal
1
2007
113
0.250
Why?
Vasculitis
1
2005
29
0.240
Why?
Pre-Eclampsia
1
2004
7
0.240
Why?
Prognosis
3
2014
825
0.230
Why?
Chlamydia trachomatis
1
2004
6
0.230
Why?
Tumor Necrosis Factor-alpha
1
2005
192
0.230
Why?
Chlamydia Infections
1
2004
7
0.230
Why?
Heart Diseases
1
2005
71
0.230
Why?
Antibodies, Monoclonal
1
2005
199
0.230
Why?
Pregnancy Complications
1
2004
52
0.220
Why?
Depressive Disorder
2
2018
186
0.220
Why?
Translations
2
2013
12
0.220
Why?
Diagnosis, Differential
3
2013
372
0.210
Why?
Comorbidity
3
2013
500
0.210
Why?
Sex Factors
2
2018
476
0.190
Why?
Cardiovascular Diseases
1
2006
372
0.190
Why?
Patient Acceptance of Health Care
1
2023
81
0.190
Why?
Vaccination
1
2021
31
0.190
Why?
Immunocompromised Host
1
2021
46
0.190
Why?
Prospective Studies
3
2020
1809
0.180
Why?
Regression Analysis
3
2020
266
0.180
Why?
Autoimmunity
2
2010
12
0.170
Why?
Health Surveys
2
2017
88
0.170
Why?
Cohort Studies
6
2017
1926
0.170
Why?
Multivariate Analysis
2
2018
331
0.170
Why?
Databases, Factual
1
2021
358
0.160
Why?
Azacitidine
1
2019
10
0.160
Why?
Age Factors
3
2016
781
0.160
Why?
Asia
1
2018
10
0.160
Why?
Enzyme Inhibitors
1
2019
120
0.160
Why?
Europe
1
2018
66
0.160
Why?
Appointments and Schedules
1
2018
14
0.160
Why?
Morbidity
1
2018
58
0.160
Why?
Mentors
1
2019
43
0.160
Why?
Arthritis, Experimental
1
2019
48
0.160
Why?
Sex Distribution
1
2018
82
0.150
Why?
Patient Acuity
1
2018
9
0.150
Why?
Workload
1
2018
33
0.150
Why?
Phenotype
4
2012
313
0.150
Why?
Faculty, Medical
1
2019
44
0.150
Why?
Biomedical Research
1
2019
66
0.150
Why?
Risk Assessment
2
2014
677
0.150
Why?
Psychiatric Status Rating Scales
1
2018
326
0.140
Why?
Pilot Projects
2
2020
440
0.140
Why?
DNA Methylation
1
2019
165
0.140
Why?
Interferon Type I
2
2017
11
0.140
Why?
Genome-Wide Association Study
4
2012
283
0.140
Why?
Blood Sedimentation
1
2017
54
0.140
Why?
Philippines
2
2017
4
0.140
Why?
Health Care Surveys
1
2017
66
0.140
Why?
CD11b Antigen
1
2017
15
0.140
Why?
Toll-Like Receptors
1
2017
17
0.140
Why?
Retrospective Studies
2
2018
3612
0.140
Why?
Illinois
1
2017
246
0.130
Why?
Macrophages
1
2017
108
0.130
Why?
Socioeconomic Factors
3
2016
309
0.130
Why?
France
1
2016
17
0.130
Why?
Health Status Disparities
1
2017
78
0.130
Why?
Mental Health
1
2017
122
0.130
Why?
Arthralgia
2
2008
125
0.130
Why?
Sleep Initiation and Maintenance Disorders
1
2017
108
0.130
Why?
Time Factors
2
2017
1491
0.130
Why?
Magnetic Resonance Imaging
2
2013
1143
0.120
Why?
Hong Kong
1
2015
2
0.120
Why?
Software
1
2015
65
0.120
Why?
Interferon Regulatory Factor-7
2
2017
4
0.120
Why?
Self Concept
2
2012
42
0.120
Why?
Cosmetic Techniques
1
2014
5
0.120
Why?
Professional-Patient Relations
1
2015
28
0.120
Why?
Double-Blind Method
1
2016
433
0.120
Why?
Observational Studies as Topic
1
2014
22
0.120
Why?
Critical Pathways
1
2014
21
0.120
Why?
Dose-Response Relationship, Drug
1
2015
351
0.120
Why?
Chi-Square Distribution
1
2014
146
0.120
Why?
Focus Groups
1
2014
93
0.110
Why?
Goals
1
2014
44
0.110
Why?
Sleep
1
2017
355
0.110
Why?
Genetic Variation
2
2011
97
0.110
Why?
Combined Modality Therapy
1
2014
307
0.110
Why?
Interferon Regulatory Factors
1
2013
2
0.110
Why?
Turkey
1
2013
6
0.110
Why?
Promoter Regions, Genetic
2
2011
96
0.110
Why?
Latin America
1
2013
5
0.110
Why?
Disease Management
1
2013
113
0.100
Why?
Matched-Pair Analysis
1
2012
30
0.100
Why?
Self-Assessment
1
2012
30
0.100
Why?
Multiple Sclerosis
1
2013
107
0.100
Why?
Quality Improvement
1
2013
161
0.100
Why?
Feedback
1
2012
33
0.100
Why?
Osteopontin
1
2011
5
0.100
Why?
Ubiquitin-Conjugating Enzymes
1
2011
5
0.100
Why?
Gene Expression Profiling
1
2012
138
0.100
Why?
Sensitivity and Specificity
1
2013
517
0.090
Why?
DEAD-box RNA Helicases
1
2011
5
0.090
Why?
Complementary Therapies
1
2011
8
0.090
Why?
DNA
4
2013
104
0.090
Why?
Genetic Association Studies
1
2011
85
0.090
Why?
Aged, 80 and over
2
2019
4857
0.090
Why?
Alleles
4
2011
221
0.090
Why?
Class III Phosphatidylinositol 3-Kinases
1
2010
1
0.090
Why?
Models, Genetic
1
2010
42
0.090
Why?
Epitopes
1
2010
48
0.090
Why?
Phosphatidylinositol 3-Kinases
1
2010
42
0.090
Why?
Disease Models, Animal
2
2019
619
0.090
Why?
Intracellular Signaling Peptides and Proteins
1
2010
53
0.080
Why?
United Kingdom
1
2010
51
0.080
Why?
Nuclear Proteins
1
2010
87
0.080
Why?
Social Environment
1
2010
81
0.080
Why?
Self-Examination
1
2009
3
0.080
Why?
Follow-Up Studies
1
2014
1859
0.080
Why?
California
3
2017
32
0.080
Why?
Animals
3
2019
3780
0.080
Why?
Cytokines
1
2010
230
0.080
Why?
Educational Status
1
2010
300
0.080
Why?
Analgesics, Non-Narcotic
1
2008
17
0.070
Why?
Biomarkers
1
2011
596
0.070
Why?
Prevalence
2
2011
468
0.070
Why?
Therapeutic Irrigation
1
2007
56
0.070
Why?
Patient Satisfaction
1
2010
328
0.070
Why?
Fatal Outcome
1
2007
57
0.070
Why?
Vulva
1
2006
2
0.070
Why?
Data Collection
1
2007
98
0.070
Why?
Injections, Intra-Articular
1
2007
91
0.070
Why?
Education, Medical, Undergraduate
1
2007
39
0.070
Why?
Joints
1
2007
69
0.070
Why?
Skin Diseases
1
2006
26
0.070
Why?
Cognition
1
2014
1353
0.060
Why?
Disability Evaluation
2
2020
289
0.060
Why?
Hepatitis B
1
2005
12
0.060
Why?
Infliximab
1
2005
17
0.060
Why?
Probability
1
2005
90
0.060
Why?
Genotype
3
2011
359
0.060
Why?
Autoimmune Diseases
2
2019
48
0.060
Why?
Pregnancy Outcome
1
2004
18
0.060
Why?
Sulfasalazine
1
2004
3
0.060
Why?
Lactones
1
2004
9
0.060
Why?
Sulfones
1
2004
20
0.060
Why?
Doxycycline
1
2004
16
0.060
Why?
Methotrexate
1
2004
36
0.060
Why?
Myocardial Infarction
1
2005
145
0.060
Why?
Drug Therapy, Combination
1
2004
183
0.060
Why?
Synovial Fluid
1
2004
95
0.050
Why?
Mice
2
2019
1461
0.050
Why?
Internship and Residency
1
2007
219
0.050
Why?
Osteoarthritis, Knee
1
2008
366
0.050
Why?
Pregnancy
1
2004
342
0.050
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2004
111
0.050
Why?
Prostaglandins A
1
2022
1
0.050
Why?
Republic of Korea
1
2022
6
0.050
Why?
Hypertension
1
2004
246
0.050
Why?
Ribonucleoproteins
2
2011
3
0.050
Why?
Cell Line
2
2012
280
0.050
Why?
Anti-Bacterial Agents
1
2004
383
0.050
Why?
Egypt
1
2020
2
0.040
Why?
Polymorphism, Genetic
2
2011
62
0.040
Why?
Chromatin Immunoprecipitation
1
2019
21
0.040
Why?
Gene Silencing
1
2019
25
0.040
Why?
Anxiety
1
2020
161
0.040
Why?
Flow Cytometry
1
2019
116
0.040
Why?
B-Lymphocytes
1
2019
56
0.040
Why?
Malaria
1
2018
4
0.040
Why?
Immunoglobulin M
1
2018
16
0.040
Why?
Complement C1q
1
2018
7
0.040
Why?
Glucocorticoids
1
2018
70
0.040
Why?
Immunoglobulin G
1
2018
95
0.040
Why?
Georgia
1
2017
11
0.040
Why?
Southeastern United States
1
2017
14
0.040
Why?
Mice, Inbred MRL lpr
1
2017
2
0.040
Why?
Interferon Regulatory Factor-3
1
2017
2
0.040
Why?
Forkhead Box Protein O3
1
2017
5
0.040
Why?
Japan
1
2016
6
0.030
Why?
Australia
1
2016
40
0.030
Why?
Proto-Oncogene Proteins c-akt
1
2017
50
0.030
Why?
Social Class
1
2017
67
0.030
Why?
Registries
1
2017
188
0.030
Why?
Child
1
2020
1420
0.030
Why?
Disabled Persons
1
2016
125
0.030
Why?
Risk Factors
2
2011
2408
0.030
Why?
3' Untranslated Regions
1
2011
5
0.020
Why?
Anemia, Hemolytic
1
2011
4
0.020
Why?
Autoantigens
1
2011
25
0.020
Why?
Thrombocytopenia
1
2011
22
0.020
Why?
Interferon-Induced Helicase, IFIH1
1
2011
1
0.020
Why?
Mexican Americans
1
2011
29
0.020
Why?
Receptors, Lysophosphatidic Acid
1
2010
1
0.020
Why?
Databases, Genetic
1
2010
8
0.020
Why?
Principal Component Analysis
1
2010
25
0.020
Why?
Antibody Specificity
1
2010
35
0.020
Why?
Aminopeptidases
1
2010
7
0.020
Why?
Tumor Necrosis Factor alpha-Induced Protein 3
1
2010
1
0.020
Why?
Protein Structure, Quaternary
1
2010
5
0.020
Why?
Immunoprecipitation
1
2010
24
0.020
Why?
Immunoblotting
1
2010
57
0.020
Why?
Genetic Loci
1
2010
51
0.020
Why?
Interferon-gamma
1
2010
82
0.020
Why?
Transfection
1
2010
121
0.020
Why?
Gene Frequency
1
2010
63
0.020
Why?
Polymerase Chain Reaction
1
2010
120
0.020
Why?
Signal Transduction
1
2011
447
0.020
Why?
Gene Expression Regulation
1
2010
281
0.020
Why?
DNA-Binding Proteins
1
2010
274
0.020
Why?
Algorithms
1
2010
377
0.020
Why?
Knee Joint
1
2008
746
0.010
Why?
Jolly's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (302)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_